Drug Discovery Chemistry 2014 | The Future of Fragments and PPIs

Dr. Erlanson of Carmot Therapeutics and Dr. Zartler of Tessera Consulting speak with CHI's Dr. Shah on March 14, 2014 about new strategies for fragment linking, different companies' fragment-based campaigns, and types of PPI-directed compounds advancing in the clinic. Dr. Erlanson will be speaking at the Fragment Based Drug Discovery meeting on April 24-25, 2014 in San Diego, part of CHI's Drug Discovery Chemistry event about Fishing for Fragments to Complement Known Binders. Dr. Zartler was the scientific advisor to Dr. Shah for the Protein-Protein Interactions meeting taking place April 23-24, 2014 in San Diego, part of CHI's Drug Discovery Chemistry event. Drs. Erlanson and Zartler are also co-instructors of one of the dinner workshops at the event, Advancing Tools and Technologies for Fragment-Based Design on April 24, 2014. Erlanson and Zartler are also co-editors of the Practical Fragments blog: http://practicalfragments.blogspot.com/